Valuing early-stage life sciences companies can be complex. Because product development can take several years and be capital intensive, obtaining an accurate valuation is essential to align management’s, the shareholders’, and current and potential investors’ understanding of estimated value. The post Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact appeared first…
New office will oversee the design, development, delivery, and operation of CMS digital products and platforms
This issue brief presents findings from the focus groups including caregiver characteristics; physical, emotional, and mental caregiving demands of caregiving; their wages, finances, and opportunities for advancement; and what caregivers would like policymakers to know about their work.
This brief examines state consent requirements for minors accessing contraceptive and abortion care, processes for minors to attempt to obtain abortion without parental involvement, and trends in state policy increasing requirements for parental involvement in minors’ health care decisions.
When people call large insurance brokerages seeking free assistance in choosing Medicare Advantage plans, they’re often offered assurances such as this one from eHealth: “Your benefit advisors will find plans that match your needs — no matter the carrier.” About a third of enrollees do seek help in making complex decisions about whether to enroll…
Many policymakers are looking for ways to reduce drug spending. Federal policymakers are not the only ones looking at the issue. In recent years, state Prescription Drug Affordability Boards (PDABs) have formed to reduce drug prices. A paper by Barthold et al. (2026) describes the what PDABs are: As of April 2025, 12 states had…
This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
The organizations that move now — with the right foundation and the right partners — will enter the next planning cycle with a specialty pharmacy that functions as a true strategic asset. The post Specialty Pharmacy Is No Longer Optional Infrastructure appeared first on MedCity News.
New Mountain Capital bringing together the Rawlings Group, Apixio’s Payment Integrity business, and VARIS
This first of a two-part article examines key challenges healthcare technology companies must address to survive the “Death Valley” curve and increase their chances for success when moving from technology development to market acceptance. The post Market Acceptance: Key Considerations for Health Tech appeared first on MedCity News.